1
BECTON DICKINSON & CO
COM
BDX
BDX
398,050
$105.1m3.67%
3.67%
Added Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 288.0k, Q2 2023 398.1k
+110.0k
+110,050
38.2%
2
KARUNA THERAPEUTICS INC
COM
COM
442,200
$95.9m3.35%
3.35%
Added Shares held: Q3 2022 431.8k, Q4 2022 299.0k, Q1 2023 403.8k, Q2 2023 442.2k
+38.4k
+38,400
9.5%
3
JAZZ PHARMACEUTICALS PLC
SHS USD
JAZZ
JAZZ
702,778
$87.1m3.04%
3.04%
Added Shares held: Q3 2022 318.3k, Q4 2022 727.5k, Q1 2023 677.9k, Q2 2023 702.8k
+24.9k
+24,878
3.7%
4
GE HEALTHCARE TECHNOLOGIES I
COMMON STOCK
GEHC
GEHC
1,045,400
$84.9m2.97%
2.97%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.0m
5
TENET HEALTHCARE CORP
COM NEW
THC
THC
990,500
$80.6m2.82%
2.82%
Reduced Shares held: Q3 2022 0, Q4 2022 717.3k, Q1 2023 1.5m, Q2 2023 990.5k
-481.5k
-481,500
-32.7%
6
ARGENX SE
SPONSORED ADR
ARGX
ARGX
184,300
$71.8m2.51%
2.51%
Reduced Shares held: Q3 2022 491.8k, Q4 2022 625.0k, Q1 2023 280.7k, Q2 2023 184.3k
-96.4k
-96,400
-34.3%
7
IDEAYA BIOSCIENCES INC
COM
IDYA
IDYA
2,985,700
$70.2m2.45%
2.45%
Reduced Shares held: Q3 2022 3.7m, Q4 2022 3.8m, Q1 2023 3.7m, Q2 2023 3.0m
-687.7k
-687,700
-18.7%
8
SURGERY PARTNERS INC
COM
SGRY
SGRY
1,555,000
$70.0m2.44%
2.44%
Reduced Shares held: Q3 2022 267.6k, Q4 2022 3.1m, Q1 2023 3.4m, Q2 2023 1.6m
-1.8m
-1,800,900
-53.7%
9
ABBVIE INC
COM
ABBV
ABBV
518,400
$69.8m2.44%
2.44%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 518.4k
10
ARVINAS INC
COM
ARVN
ARVN
2,773,189
$68.8m2.40%
2.40%
Reduced Shares held: Q3 2022 4.3m, Q4 2022 5.0m, Q1 2023 4.3m, Q2 2023 2.8m
-1.5m
-1,500,711
-35.1%
11
ZENTALIS PHARMACEUTICALS INC
COM
ZNTL
ZNTL
2,334,000
$65.8m2.30%
2.30%
Reduced Shares held: Q3 2022 4.2m, Q4 2022 5.2m, Q1 2023 2.9m, Q2 2023 2.3m
-595.3k
-595,300
-20.3%
12
NEUROCRINE BIOSCIENCES INC
COM
NBIX
NBIX
665,316
$62.7m2.19%
2.19%
Reduced Shares held: Q3 2022 1.9m, Q4 2022 1.8m, Q1 2023 815.7k, Q2 2023 665.3k
-150.4k
-150,384
-18.4%
13
ELI LILLY & CO
COM
LLY
LLY
133,000
$62.4m2.18%
2.18%
New Shares held: Q3 2022 1.0m, Q4 2022 217.0k, Q1 2023 0, Q2 2023 133.0k
14
SYNDAX PHARMACEUTICALS INC
COM
SNDX
SNDX
2,872,000
$60.1m2.10%
2.10%
Reduced Shares held: Q3 2022 5.6m, Q4 2022 5.9m, Q1 2023 3.9m, Q2 2023 2.9m
-993.3k
-993,300
-25.7%
15
UNIVERSAL HLTH SVCS INC
CL B
UHS
UHS
370,100
$58.4m2.04%
2.04%
Reduced Shares held: Q3 2022 0, Q4 2022 825.6k, Q1 2023 670.0k, Q2 2023 370.1k
-299.9k
-299,900
-44.8%
16
BIO RAD LABS INC
CL A
BIO
BIO
152,600
$57.9m2.02%
2.02%
Reduced Shares held: Q3 2022 144.8k, Q4 2022 92.2k, Q1 2023 221.5k, Q2 2023 152.6k
-68.9k
-68,900
-31.1%
17
CENCORA INC
COM
COR
COR
300,000
$57.7m2.02%
2.02%
Added Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 126.6k, Q2 2023 300.0k
+173.4k
+173,400
137.0%
18
PACIFIC BIOSCIENCES CALIF IN
COM
PACB
PACB
4,337,400
$57.7m2.01%
2.01%
Added Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 3.8m, Q2 2023 4.3m
+524.8k
+524,800
13.8%
19
LEGEND BIOTECH CORP
SPONSORED ADS
LEGN
LEGN
798,900
$55.1m1.93%
1.93%
Reduced Shares held: Q3 2022 0, Q4 2022 970.0k, Q1 2023 1.1m, Q2 2023 798.9k
-321.6k
-321,600
-28.7%
20
BIOGEN INC
COM
BIIB
BIIB
174,000
$49.6m1.73%
1.73%
Added Shares held: Q3 2022 600.0k, Q4 2022 0, Q1 2023 128.8k, Q2 2023 174.0k
+45.2k
+45,200
35.1%
21
AKERO THERAPEUTICS INC
COM
AKRO
AKRO
1,025,000
$47.9m1.67%
1.67%
Reduced Shares held: Q3 2022 3.1m, Q4 2022 3.8m, Q1 2023 2.4m, Q2 2023 1.0m
-1.4m
-1,422,000
-58.1%
22
CUREVAC N V
COM
CVAC
CVAC
4,300,000
$44.8m1.56%
1.56%
Added Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 3.5m, Q2 2023 4.3m
+750.0k
+750,000
21.1%
23
ACADIA HEALTHCARE COMPANY IN
COM
ACHC
ACHC
550,000
$43.8m1.53%
1.53%
Reduced Shares held: Q3 2022 1.4m, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 550.0k
-615.3k
-615,300
-52.8%
24
VAXCYTE INC
COM
PCVX
PCVX
875,000
$43.7m1.53%
1.53%
Added Shares held: Q3 2022 628.7k, Q4 2022 1.6m, Q1 2023 510.0k, Q2 2023 875.0k
+365.0k
+365,000
71.6%
25
MCKESSON CORP
COM
MCK
MCK
101,200
$43.2m1.51%
1.51%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 101.2k
26
APELLIS PHARMACEUTICALS INC
COM
APLS
APLS
468,700
$42.7m1.49%
1.49%
New Shares held: Q3 2022 844.0k, Q4 2022 0, Q1 2023 0, Q2 2023 468.7k
27
BOSTON SCIENTIFIC CORP
COM
BSX
BSX
785,700
$42.5m1.48%
1.48%
Reduced Shares held: Q3 2022 2.5m, Q4 2022 3.3m, Q1 2023 850.0k, Q2 2023 785.7k
-64.3k
-64,300
-7.6%
28
ULTRAGENYX PHARMACEUTICAL IN
COM
RARE
RARE
900,700
$41.5m1.45%
1.45%
Reduced Shares held: Q3 2022 2.1m, Q4 2022 3.0m, Q1 2023 2.1m, Q2 2023 900.7k
-1.2m
-1,226,200
-57.6%
29
PFIZER INC
COM
PFE
PFE
1,117,467
$41.0m1.43%
1.43%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.1m
30
IMMUNOVANT INC
COM
IMVT
IMVT
2,085,000
$39.6m1.38%
1.38%
Added Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.0m, Q2 2023 2.1m
+1.0m
+1,042,000
99.9%
31
AXSOME THERAPEUTICS INC
COM
AXSM
AXSM
545,000
$39.2m1.37%
1.37%
Reduced Shares held: Q3 2022 1.5m, Q4 2022 670.0k, Q1 2023 619.2k, Q2 2023 545.0k
-74.2k
-74,200
-12.0%
32
IMMUNOGEN INC
COM
IMGN
IMGN
1,997,800
$37.7m1.32%
1.32%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.0m
33
ZOETIS INC
CL A
ZTS
ZTS
217,000
$37.4m1.31%
1.31%
Reduced Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 407.5k, Q2 2023 217.0k
-190.5k
-190,500
-46.8%
34
PROTHENA CORP PLC
SHS
PRTA
PRTA
535,000
$36.5m1.28%
1.28%
Reduced Shares held: Q3 2022 2.0m, Q4 2022 3.0m, Q1 2023 1.1m, Q2 2023 535.0k
-533.2k
-533,200
-49.9%
35
VIR BIOTECHNOLOGY INC
COM
VIR
VIR
1,425,000
$35.0m1.22%
1.22%
Reduced Shares held: Q3 2022 0, Q4 2022 850.0k, Q1 2023 1.6m, Q2 2023 1.4m
-215.2k
-215,200
-13.1%
36
IMMUNOCORE HLDGS PLC
ADS
IMCR
IMCR
575,000
$34.5m1.20%
1.20%
Reduced Shares held: Q3 2022 2.1m, Q4 2022 1.2m, Q1 2023 769.8k, Q2 2023 575.0k
-194.8k
-194,800
-25.3%
37
SAREPTA THERAPEUTICS INC
COM
SRPT
SRPT
297,500
$34.1m1.19%
1.19%
Reduced Shares held: Q3 2022 948.2k, Q4 2022 1.1m, Q1 2023 416.0k, Q2 2023 297.5k
-118.5k
-118,500
-28.5%
38
ARROWHEAD PHARMACEUTICALS IN
COM
ARWR
ARWR
925,000
$33.0m1.15%
1.15%
Reduced Shares held: Q3 2022 1.3m, Q4 2022 1.4m, Q1 2023 1.7m, Q2 2023 925.0k
-816.3k
-816,300
-46.9%
39
BIOHAVEN LTD
COM
BHVN
BHVN
1,325,000
$31.7m1.11%
1.11%
Reduced Shares held: Q3 2022 0, Q4 2022 1.5m, Q1 2023 1.5m, Q2 2023 1.3m
-162.2k
-162,200
-10.9%
40
REVOLUTION MEDICINES INC
COM
RVMD
RVMD
1,075,000
$28.8m1.00%
1.00%
Reduced Shares held: Q3 2022 2.3m, Q4 2022 2.5m, Q1 2023 1.3m, Q2 2023 1.1m
-269.8k
-269,800
-20.1%
41
PRIVIA HEALTH GROUP INC
COM
PRVA
PRVA
1,079,806
$28.2m0.98%
0.98%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.1m
42
PHATHOM PHARMACEUTICALS INC
COM
PHAT
PHAT
1,949,700
$27.9m0.98%
0.98%
Reduced Shares held: Q3 2022 1.9m, Q4 2022 1.9m, Q1 2023 2.0m, Q2 2023 1.9m
-98.9k
-98,900
-4.8%
43
BAXTER INTL INC
COM
BAX
BAX
604,700
$27.6m0.96%
0.96%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 604.7k
44
FUSION PHARMACEUTICALS INC
COM
COM
5,700,000
$26.6m0.93%
0.93%
Unchanged Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 5.7m, Q2 2023 5.7m
45
ROCKET PHARMACEUTICALS INC
COM
RCKT
RCKT
1,326,000
$26.3m0.92%
0.92%
Added Shares held: Q3 2022 0, Q4 2022 1.5m, Q1 2023 1.2m, Q2 2023 1.3m
+81.6k
+81,600
6.6%
46
BLUEPRINT MEDICINES CORP
COM
BPMC
BPMC
415,000
$26.2m0.92%
0.92%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 415.0k
47
EDITAS MEDICINE INC
COM
EDIT
EDIT
3,000,000
$24.7m0.86%
0.86%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 3.0m
48
VENTYX BIOSCIENCES INC
COM
VTYX
VTYX
692,500
$22.7m0.79%
0.79%
Reduced Shares held: Q3 2022 0, Q4 2022 1.3m, Q1 2023 1.9m, Q2 2023 692.5k
-1.2m
-1,225,300
-63.9%
49
NATERA INC
COM
NTRA
NTRA
432,900
$21.1m0.74%
0.74%
Added Shares held: Q3 2022 1.7m, Q4 2022 1.8m, Q1 2023 249.9k, Q2 2023 432.9k
+183.0k
+183,000
73.2%
50
LANTHEUS HLDGS INC
COM
LNTH
LNTH
245,100
$20.6m0.72%
0.72%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 245.1k
51
MOONLAKE IMMUNOTHERAPEUTICS
CLASS A ORD
MLTX
MLTX
400,000
$20.4m0.71%
0.71%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 400.0k
52
VERONA PHARMA PLC
SPONSORED ADS
VRNA
VRNA
954,500
$20.2m0.70%
0.70%
Added Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 878.8k, Q2 2023 954.5k
+75.7k
+75,700
8.6%
53
AMYLYX PHARMACEUTICALS INC
COM
AMLX
AMLX
901,400
$19.4m0.68%
0.68%
Added Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 900.0k, Q2 2023 901.4k
+1.4k
+1,400
0.2%
54
AXONICS INC
COM
AXNX
AXNX
379,700
$19.2m0.67%
0.67%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 379.7k
55
XENON PHARMACEUTICALS INC
COM
XENE
XENE
481,300
$18.5m0.65%
0.65%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 481.3k
56
REGENERON PHARMACEUTICALS
COM
REGN
REGN
24,800
$17.8m0.62%
0.62%
Reduced Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 119.1k, Q2 2023 24.8k
-94.3k
-94,300
-79.2%
57
ROIVANT SCIENCES LTD
SHS
ROIV
ROIV
1,687,500
$17.0m0.59%
0.59%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.7m
58
PLIANT THERAPEUTICS INC
COM
PLRX
PLRX
916,600
$16.6m0.58%
0.58%
Reduced Shares held: Q3 2022 2.0m, Q4 2022 2.2m, Q1 2023 2.7m, Q2 2023 916.6k
-1.7m
-1,748,400
-65.6%
59
VERVE THERAPEUTICS INC
COM
COM
878,600
$16.5m0.58%
0.58%
Reduced Shares held: Q3 2022 1.0m, Q4 2022 1.6m, Q1 2023 1.4m, Q2 2023 878.6k
-473.1k
-473,100
-35.0%
60
INTELLIA THERAPEUTICS INC
COM
NTLA
NTLA
395,855
$16.1m0.56%
0.56%
Reduced Shares held: Q3 2022 999.1k, Q4 2022 638.2k, Q1 2023 417.0k, Q2 2023 395.9k
-21.1k
-21,145
-5.1%
61
CEREVEL THERAPEUTICS HLDNG I
COM
CERE
CERE
501,200
$15.9m0.56%
0.56%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 501.2k
62
ACELYRIN INC
COM
COM
750,000
$15.7m0.55%
0.55%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 750.0k
63
POINT BIOPHARMA GLOBAL INC
COM
COM
1,671,800
$15.1m0.53%
0.53%
Reduced Shares held: Q3 2022 2.8m, Q4 2022 2.4m, Q1 2023 2.4m, Q2 2023 1.7m
-739.8k
-739,800
-30.7%
64
KARYOPHARM THERAPEUTICS INC
COM
COM
8,370,100
$15.0m0.52%
0.52%
Reduced Shares held: Q3 2022 0, Q4 2022 9.6m, Q1 2023 9.6m, Q2 2023 8.4m
-1.3m
-1,263,811
-13.1%
65
KEZAR LIFE SCIENCES INC
COM
COM
6,080,000
$14.9m0.52%
0.52%
Reduced Shares held: Q3 2022 5.4m, Q4 2022 6.8m, Q1 2023 6.5m, Q2 2023 6.1m
-439.4k
-439,400
-6.7%
66
SCHRODINGER INC
COM
SDGR
SDGR
274,900
$13.7m0.48%
0.48%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 274.9k
67
2SEVENTY BIO INC
COMMON STOCK
TSVT
TSVT
1,342,000
$13.6m0.47%
0.47%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.3m
68
MINERALYS THERAPEUTICS INC
COM
MLYS
MLYS
766,700
$13.1m0.46%
0.46%
Reduced Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.3m, Q2 2023 766.7k
-497.1k
-497,100
-39.3%
69
MERSANA THERAPEUTICS INC
COM
COM
3,790,000
$12.5m0.44%
0.44%
Added Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 3.4m, Q2 2023 3.8m
+356.8k
+356,767
10.4%
70
CARIBOU BIOSCIENCES INC
COM
CRBU
CRBU
2,758,600
$11.7m0.41%
0.41%
Unchanged Shares held: Q3 2022 3.2m, Q4 2022 2.9m, Q1 2023 2.8m, Q2 2023 2.8m
71
NANOSTRING TECHNOLOGIES INC
COM
NSTG
NSTG
2,700,400
$10.9m0.38%
0.38%
Added Shares held: Q3 2022 698.2k, Q4 2022 2.1m, Q1 2023 2.2m, Q2 2023 2.7m
+483.4k
+483,400
21.8%
72
ALPINE IMMUNE SCIENCES INC
COM
NVLS
NVLS
1,058,500
$10.9m0.38%
0.38%
Added Shares held: Q3 2022 998.6k, Q4 2022 1.0m, Q1 2023 989.5k, Q2 2023 1.1m
+69.0k
+69,000
7.0%
73
INARI MED INC
COM
NARI
NARI
175,000
$10.2m0.36%
0.36%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 175.0k
74
89BIO INC
COM
ETNB
ETNB
526,376
$10.0m0.35%
0.35%
Reduced Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.8m, Q2 2023 526.4k
-1.3m
-1,316,600
-71.4%
75
AC IMMUNE SA
SHS
ACIU
ACIU
2,903,278
$8.6m0.30%
0.30%
Added Shares held: Q3 2022 274.9k, Q4 2022 325.4k, Q1 2023 325.4k, Q2 2023 2.9m
+2.6m
+2,577,878
792.2%
76
DENALI THERAPEUTICS INC
COM
DNLI
DNLI
282,752
$8.3m0.29%
0.29%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 282.8k
77
COLLEGIUM PHARMACEUTICAL INC
COM
COLL
COLL
354,100
$7.6m0.27%
0.27%
Reduced Shares held: Q3 2022 0, Q4 2022 37.9k, Q1 2023 385.5k, Q2 2023 354.1k
-31.4k
-31,400
-8.2%
78
ALPHATEC HLDGS INC
COM NEW
ATEC
ATEC
393,000
$7.1m0.25%
0.25%
New Shares held: Q3 2022 1.7m, Q4 2022 0, Q1 2023 0, Q2 2023 393.0k
79
AN2 THERAPEUTICS INC
COM
ANTX
ANTX
657,200
$5.6m0.20%
0.20%
Reduced Shares held: Q3 2022 742.6k, Q4 2022 743.6k, Q1 2023 723.2k, Q2 2023 657.2k
-66.0k
-66,000
-9.1%
80
GRITSTONE BIO INC
COM
GRTS
GRTS
2,765,500
$5.4m0.19%
0.19%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.8m
81
COMPASS THERAPEUTICS INC
COM
CMPX
CMPX
1,620,200
$5.2m0.18%
0.18%
Reduced Shares held: Q3 2022 2.0m, Q4 2022 2.0m, Q1 2023 1.8m, Q2 2023 1.6m
-204.8k
-204,800
-11.2%
82
SCYNEXIS INC
COM NEW
COM NEW
1,738,734
$5.1m0.18%
0.18%
New Shares held: Q3 2022 1.1m, Q4 2022 1.1m, Q1 2023 0, Q2 2023 1.7m
83
SYROS PHARMACEUTICALS INC
COM NEW
SYRS
SYRS
1,464,034
$4.6m0.16%
0.16%
Added Shares held: Q3 2022 900.0k, Q4 2022 900.0k, Q1 2023 904.6k, Q2 2023 1.5m
+559.4k
+559,404
61.8%
84
ALTIMMUNE INC
COM NEW
ALT
ALT
1,174,100
$4.1m0.14%
0.14%
Reduced Shares held: Q3 2022 2.7m, Q4 2022 4.0m, Q1 2023 1.3m, Q2 2023 1.2m
-141.1k
-141,100
-10.7%
85
CENTURY THERAPEUTICS INC
COM
IPSC
IPSC
1,110,900
$3.5m0.12%
0.12%
Reduced Shares held: Q3 2022 1.3m, Q4 2022 1.3m, Q1 2023 1.3m, Q2 2023 1.1m
-157.2k
-157,200
-12.4%
86
HYPERFINE INC
COM CL A
HYPR
HYPR
1,188,178
$2.6m0.09%
0.09%
Reduced Shares held: Q3 2022 1.5m, Q4 2022 1.5m, Q1 2023 1.5m, Q2 2023 1.2m
-315.6k
-315,576
-21.0%
87
SIMULATIONS PLUS INC
COM
COM
45,900
$2.0m0.07%
0.07%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 45.9k
88
CAREMAX INC
COM CL A
COM CL A
636,000
$2.0m0.07%
0.07%
Reduced Shares held: Q3 2022 755.3k, Q4 2022 755.3k, Q1 2023 755.3k, Q2 2023 636.0k
-119.3k
-119,329
-15.8%
89
BAUSCH HEALTH COS INC
COM
BHC
BHC
215,100
$1.7m0.06%
0.06%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 215.1k
90
STRUCTURE THERAPEUTICS INC
SPONSORED ADS
GPCR
GPCR
37,800
$1.6m0.05%
0.05%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 37.8k
91
EXSCIENTIA PLC
ADS
EXAI
EXAI
127,600
$755.4k0.03%
0.03%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 127.6k
92
ARTERIS INC
COM
AIP
AIP
75,500
$514.9k0.02%
0.02%
New Shares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 75.5k
93
NUVATION BIO INC
*W EXP 07/07/202
NUVB.WS
NUVB.WS
90,560
$15.0k0.00%
0.00%
Reduced Shares held: Q3 2022 100.0k, Q4 2022 100.0k, Q1 2023 100.0k, Q2 2023 90.6k
-9.4k
-9,439
-9.4%